Company
AQ Biotech´s start goes back to 2017 with the aim to improve the early detection of diseases using biological sampling and the E-TRF method. After a groundbreaking innovation in late 2020 to engineer the M13 phage to have affinity towards a specific color dye, the company started extensive R&D efforts to apply it to other phages and to detect diseases, which are hard to diagnose.
Today, the company has a strong patent portfolio around the phage-biosensor method. AQ Biotech works together with world class science institutes and their clinical researchers in Finland, China and in the US, applying its biosensor method to revolutionize early detection of diseases.
Team
Our team consists of people with different backgrounds and skills, but all share a common goal – to improve healthcare, screening and diagnostics with innovative and scientifically-backed solutions.
Jukka Holappa, PhD
Chief Business Officer & co-OWNER
Operations and business lead.
jukka.holappa@aqbiotech.com
Janne Kulpakko, PhD
CHIEF SCIENCE OFFICER & CO-FOUNDER
Leading the company’s research work and new application development.
janne.kulpakko@aqbiotech.com
Zhao Zhao, PhD
DIRECTOR
Management of the company’s research and preclinical trials in China.
zhao.zhao@aqbiotech.com
Sini Huuskonen, PhD
PRINCIPAL SCIENTIST
Biosensor development lead.
sini.huuskonen@aqbiotech.com
Satu Tiittanen
SENIOR SCIENTIST & Quality lead
Biosensor research and Quality Management.
satu..tiittanen@aqbiotech.com
Elizabeth Cudjoe
SENIOR APPLICATION SCIENTIST
Phage-biosensor research and test development.
elizabeth.cudjoe@aqbiotech.com
Elinda Helin
SENIOR APPLICATION SCIENTIST
Phage-biosensor research and test development.
elinda.helin@aqbiotech.com
Raakel Lehmusmäki
APPLICATION SCIENTIST
Phage-biosensor research and test development.
raakel.lehmusmaki@aqbiotech.com
Senior Clinical Advisors
Antti Rannikko
Professor of Urology at Helsinki University Hospital.
Maria Sundvall
MD Phd, Specialist Physician in Clinical Oncology at Turku University Hospital.
Valtteri Kaasinen
MD, PhD and Professor of Neurology in Clinical Neurosciences at Turku University Hospital.
Linda Eva Amoah
Associate Professor of Immunology at the Noguchi Memorial Institute for Medical Research.
Tambet Teesalu
Professor of Nanomedicine and the head of the Laboratory of Precision and Nanomedicine at the University of Tartu.